New Haven, Conn. — Researchers at the Yale Liver Center found that patients with COVID-19 presented with abnormal liver tests at much higher rates than suggested by earlier studies. They also discovered that higher levels of liver enzymes — proteins released when the liver is damaged — were associated with poorer outcomes for these patients, including ICU admission, mechanical ventilation, and death.
- Football-loving states slow to enact youth concussion laws
- Lab results don’t explain ‘obesity paradox,’ but bias may
- New device offers faster way to detect antibiotic-resistant bacteria
- Flashy lizards are more attractive to mates and to predators
- Octapharma USA presents bleeding disorders research at virtual ASH annual meeting